## Beta-Adrenergic Receptor Antagonism: Cardiovascular Effects ### Mechanism of Non-Selective Beta-Blockade **Key Point:** Non-selective beta-blockers antagonize both β₁ and β₂ receptors throughout the cardiovascular system, producing predictable hemodynamic changes. **High-Yield:** The most common and therapeutically exploited effect is **decreased heart rate (negative chronotropic effect) and decreased cardiac contractility (negative inotropic effect)**. These occur because: 1. **β₁-receptor blockade in the heart:** - Reduces cAMP production - Decreases calcium influx into myocardial cells - Lowers heart rate and force of contraction 2. **Clinical manifestation:** - Resting heart rate typically falls by 10–20 bpm - Cardiac output decreases proportionally - Myocardial oxygen demand ↓ (therapeutic benefit in angina and post-MI) ### Why This Is the "Most Common" Effect This is the **primary and most consistent** hemodynamic change observed in virtually every patient receiving a non-selective beta-blocker. It is the basis for their use in hypertension, angina, arrhythmias, and heart failure. **Clinical Pearl:** The decrease in heart rate is so reliable that failure to achieve bradycardia (< 55 bpm target in many protocols) suggests either poor adherence or inadequate dosing. **Mnemonic:** **ABCDE of Beta-Blockers** — **A**rrhythmia control, **B**lood pressure ↓, **C**ontractility ↓, **D**emand ↓, **E**xercise tolerance ↓. The C and D components reflect the most common effects. ### Comparison with Selective β₁-Blockade | Feature | Non-Selective (β₁ + β₂) | Selective β₁-Blockade | |---------|--------------------------|----------------------| | Heart rate | ↓↓ (marked) | ↓ (moderate) | | Contractility | ↓↓ (marked) | ↓ (moderate) | | Peripheral resistance | ↑ (β₂ blockade unopposed) | → or ↓ (less resistance) | | Bronchial tone | ↑ (risk of bronchospasm) | Minimal risk | [cite:KD Tripathi 8e Ch 10]
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.